High drug prices a target of opportunity for divided Congress

Washington Times

14 November 2018 - In January, Democrats will hold the majority in the House, dealing a crushing blow to much of the legislative agenda advanced by President Trump and Republicans on Capitol Hill.

But a divided Congress, with Democrats holding a majority in the House and Republicans maintaining control in the Senate, means that any legislation that can pass must be bipartisan.

The parties are far apart on a range of hot-button issues, from immigration and taxes to energy. But there is a bipartisan interest in reducing drug prices and the stars may be aligning in January for some legislative action.

Read Washington Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing